Medications
Hospital group fights drug shortages by making needed meds
U.S. hospitals fed up with shortages of critical medicines—mostly generic drugs that aren't profitable—have banded together.
Jan 26, 2020
0
9
Page 10 - News tagged with drug approval
Medications
Evolution of approval, regulation processes for drugs explored
(HealthDay)—The U.S. approval and regulation processes for pharmaceutical agents have evolved during the last four decades, according to a study published in the Jan. 14 issue of the Journal of the American Medical Association.
Jan 15, 2020
0
0
Medical research
Multiple sclerosis: New standards required for planning clinical trials
How can the perspectives of patients with multiple sclerosis (MS) be given more consideration in clinical trials? This question was investigated and corresponding recommendations were developed by a working group of the Drug ...
Dec 18, 2019
0
1
Medications
FDA panel: Expand use of fish oil drug Vascepa
Approved use of the prescription-strength fish oil drug Vascepa should be widened to include more patients at risk for heart attack and stroke, a U.S. Food and Drug Administration advisory panel recommended Thursday.
Nov 18, 2019
0
3
Alzheimer's disease & dementia
Biogen reanalyzes studies, presses ahead on Alzheimer's drug
Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia.
Oct 22, 2019
0
7
Medications
One-third of pre-approved prescription drugs have not completed the FDA approval process
The Food and Drug Administration's (FDA) Accelerated Approval Program was created in 1992 to significantly accelerate the ability to bring certain new drugs to market. New research to be published in an upcoming issues of ...
Aug 26, 2019
0
0
Inflammatory disorders
Peptides that mimic 'good cholesterol' reverse inflammatory bowel disease in mice
Peptides that mimic the function of HDL cholesterol, which has been dubbed "good cholesterol," can treat the underlying inflammation associated with inflammatory bowel disease, or IBD, according to new research in mice. The ...
Jun 12, 2019
0
2
Medications
FDA: Pulmonary embolism risk up with tofacitinib 10 mg for RA
(HealthDay)—A safety clinical trial has revealed that tofacitinib (Xeljanz, Xeljanz XR) 10 mg twice daily is associated with an increased risk for pulmonary embolism (PE) and death among patients with rheumatoid arthritis ...
Mar 1, 2019
0
5
Diseases, Conditions, Syndromes
Review finds antibiotic development increased, but insufficient
While the pipeline of new antibiotics has improved over the past six years, momentum in the development of new infection-fighting agents remains inadequate and could take a significant downturn without new incentives, a report ...
Feb 6, 2019
0
0
Medical research
FDA warns companies on dangerous, unapproved stem cell treatments
(HealthDay)—After infections tied to unapproved stem cell treatments sent 12 people to hospital this past year, the U.S. Food and Drug Administration on Thursday issued a stern warning about the products.
Dec 21, 2018
0
5
